Palivizumab (Synagis)--cohorting babies to reduce waste.
Seeler
R A
RA
Schatz
B
B
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000191:economics; D061067:Antibodies, Monoclonal, Humanized; D001071:Appointments and Schedules; D017046:Cost Savings; D004349:Drug Packaging; D006801:Humans; D007223:Infant; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy* / Q000191:economics; D012136:Respiratory Syncytial Viruses
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069455:Palivizumab